代表性论文
1. Han H, Wang W. A tale of two Hippo pathway modules. EMBO J. 2023 Jun 1;42(11):e113970.
2. Han H, Nakaoka HJ, Hofmann L, Zhou JJ, Yu C, et al., The Hippo pathway kinases LATS1 and LATS2 attenuate cellular responses to heavy metals through phosphorylating MTF1. Nat Cell Biol. 2022 Jan 13; 24:74–87.
3. Chen Y#, Han H#, Seo G, Vargas RE, Yang B, et al., Systematic analysis of the Hippo pathway organization and oncogenic alteration in evolution. Sci Rep. 2020 Feb 21;10(1):3173. (#co-first authors)
4. Vargas RE#, Duong VT#, Han H#, Ta AP, Chen Y, et al., Elucidation of WW domain ligand binding specificities in the Hippo pathway reveals STXBP4 as YAP inhibitor. EMBO J. 2020 Jan 2;39(1):e102406. (#co-first authors)
5. Han H, Qi R, Zhou JJ, Ta AP, Yang B, et al., Regulation of the Hippo pathway by phosphatidic acid-mediated lipid-protein interaction. Mol Cell. 2018 Oct 18;72(2):328-340.e8.
6. Han H, Yang B, Nakaoka HJ, Yang J, Zhao Y, et al., Hippo signaling dysfunction induces cancer cell addiction to YAP. Oncogene. 2018 Aug 1.
7. Zheng X#, Han H#, Liu G#, Ma Y, Pan R, et al., LncRNA wires up Hippo and hedgehog signaling to reprogram glucose metabolism. EMBO J. 2017 Sep 28. pii: e201797609. (#co-first authors)
8. Han H, Yang B, Wang W. Angiomotin-like 2 interacts with and negatively regulates AKT. Oncogene. 2017 Aug 10;36(32):4662-4669.
9. Li X#, Han H#, Zhou MT#, Yang B, Ta AP, et al., Proteomic analysis of the human tankyrase protein interaction network reveals its role in pexophagy. Cell Rep. 2017 Jul 18;20(3):737-749. (#co-first authors)
10. Han H, Li W, Shen H, Zhang J, Zhu Y, et al., microRNA-129-5p, a c-Myc negative target, affects hepatocellular carcinoma progression by blocking the Warburg effect. J Mol Cell Biol. 2016 Mar 21;
11. Han H, Sun D, Li W, Shen H, Zhu Y, et al., A c-Myc-MicroRNA functional feedback loop affects hepatocarcinogenesis. Hepatology. 2013 Jun;57(6):2378-89.
Complete list of published work:
https://www.ncbi.nlm.nih.gov/myncbi/1teutjgq9dwQu/bibliography/public/
